Wells Fargo
BTTX

Wells Fargo’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Wells Fargo’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-179
Closed -$35 – 7775
2023
Q4 		$35 Buy
179
+58
+48% +$13 ﹤0.01% 7034
2023
Q3 		$44 Buy
121
+4
+3% +$3 ﹤0.01% 6956
2023
Q2 		$126 Buy
117
+60
+105% +$58 ﹤0.01% 6824
2023
Q1 		$40 Hold
57
– – ﹤0.01% 7174
2022
Q4 		$63 Buy
57
+2
+4% +$3 ﹤0.01% 6936
2022
Q3 		$0 Sell
55
-10
-15% -$18 ﹤0.01% 7718
2022
Q2 		$0 Buy
65
+5
+8% +$8 ﹤0.01% 7825
2022
Q1 		$0 Buy
60
+1
+2% +$3 ﹤0.01% 8143
2021
Q4 		$0 Buy
+59
New +$484 ﹤0.01% 8078

Other funds holding BTTX

CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.37B AUM 20.71% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $443M AUM 14.48% 1-Year Est. Return